# Medtronic Completes $550M Acquisition of Neurovascular Company

> ma · REPORTED · 2026-07-01

Medtronic completed a $550 million acquisition of a neurovascular company, further expanding its stroke and neurovascular intervention portfolio, as reported in a July 2026 healthcare M&A roundup.

About Medtronic: Medtronic is a global medical device leader offering a broad portfolio of therapies across cardiac rhythm, neurovascular, spine, surgical, and other clinical areas serving hospitals and health systems worldwide.

- Company: Medtronic
- Sector: medical devices
- Primary source: https://healthexec.com/topics/healthcare-management/mergers-and-acquisitions/tempus-buys-cancer-diagnostics-firm-personalis-15b

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.